Renaissance Technologies
RPTP

Renaissance Technologies’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Renaissance Technologies’s Portfolio RPTP Stock Details RPTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-126,480
Closed -$1.14M – 3704
2016
Q3 		$1.14M Buy
+126,480
New +$899K ﹤0.01% 2509
2016
Q2 		– Sell
-572,946
Closed -$2.64M – 3749
2016
Q1 		$2.64M Buy
572,946
+40,066
+8% +$161K 0.01% 2040
2015
Q4 		$2.77M Buy
532,880
+286,860
+117% +$1.66M 0.01% 1901
2015
Q3 		$1.49M Buy
+246,020
New +$3.01M ﹤0.01% 2163

Renaissance Technologies's RPTP Position: Q4 2016 in Review

Renaissance Technologies sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q4 2016, closing a stake of 126,480 shares — an estimated $1.14M sold.

Renaissance Technologies first reported a position in RPTP in Q3 2015 and held it in 4 quarters. The position peaked at $2.77M in Q4 2015. 0 funds tracked by Wall St. Rank hold RPTP as of Q4 2016.

  • Renaissance Technologies reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q4 2016 after selling out during the quarter.
  • Renaissance Technologies sold 126,480 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q4 2016, an estimated $1.14M.
  • Renaissance Technologies first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q3 2015 and held it in 4 quarters.
  • Renaissance Technologies's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $2.77M in Q4 2015.
  • 0 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q4 2016.

Based on Renaissance Technologies's 13F filing for Q4 2016, filed 13 Feb 2017.